Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F3F4U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,897
Award facts
- Contract value 100% obligated
- $34,896.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,896.86 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen 2 mL injections under a firm fixed price contract. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025, and no set-aside designation was utilized. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen regularly fulfills federal medical requirements through competitively awarded contracts with the DLA Medical Supply Chain, supporting customers including the Defense Health Agency and U.S. Coast Guard with a diverse pharmaceutical portfolio ranging from brand-name and generic drugs to specialized medical devices.
Quick answers
Who was awarded contract SPE2DR26F3F4U?
SPE2DR26F3F4U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F3F4U worth?
The government has obligated $34,897 on SPE2DR26F3F4U.
Is contract SPE2DR26F3F4U an order under another contract?
Yes. SPE2DR26F3F4U is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3F4U competed?
The extent of competition for SPE2DR26F3F4U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award